DEAL NOTE: Crowell & Moring Advises Humana Inc. on Acquisition of Enclara Healthcare

Washington – December 16, 2019: Crowell & Moring advised Humana Inc. on its proposed acquisition of Enclara Healthcare, one of the nation’s largest hospice pharmacy and benefit management providers, from Consonance Capital Partners. The Enclara acquisition provides Humana with the opportunity to extend its comprehensive care continuum strategy to cover the pharmacy-related needs associated with hospice care, simplify the mail order pharmacy experience, and advance its technology stack for in-home pharmacy through areas such as enhanced mobile medication management and improved electronic medical record (EMR) connectivity.

The transaction will include the acquisition of Enclara Pharmacia, Guidant Rx and Avanti Health Care Services and is expected to close in the first half of 2020 after going through the customary regulatory approvals at state and federal levels.

Crowell & Moring served as legal counsel for Humana using a cross-practice team to support the acquisition, including members of the corporate, health care, and tax practices. Partners involved in the transaction were Paul Pollock, Stephanie Marcantonio, Troy Barsky, Charlie Hwang, David McFarlane, Shawn Johnson, Evan Wolff, and Scott Moore.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with more than 550 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, D.C., New York, Los Angeles, San Francisco, Orange County, London, and Brussels.